Pfizer, Inc. v. Teva Pharms. USA Inc.

Federal Circuit: March 7, 2008

Appeal from the District of New Jersey

Before: Dyk, Michel, Kennelly

Full Text: PDF

Tagged: ip

Authorities Cited: United States Patent and Trademark Office U.S. Patent No. 5,466,823 U.S. Patent No. 5,474,995 U.S. Patent No. 5,760,068 United States Code 21 U.S.C. § 355 21 U.S.C. § 355(j)(2)(A) 28 U.S.C. § 1295(a)(1) 35 U.S.C. § 102 35 U.S.C. § 102(e) 35 U.S.C. § 112 35 U.S.C. § 121 35 U.S.C. § 271(e) Supreme Court 192 U.S. 543 500 U.S. 90, 99 508 U.S. 83 Circuit Courts 83 F.2d 279, 282-283 152 F.2d 991, 993 189 F.2d 660, 661 203 F.2d 726 784 F.2d 351, 355-358 916 F.2d 683, 688-689 195 F.3d 1322, 1326 251 F.3d 955, 967 276 F.3d 1368, 1370-1371 278 F.3d 1288, 1297 284 F.3d 1323, 1334 284 F.3d 1335, 1356 301 F.3d 1306, 1320 327 F.3d 1357 349 F.3d 1373, 1382-1386 358 F.3d 916, 917-918 437 F.3d 1181, 1191 437 F.3d 1309, 1314 476 F.3d 1359, 1363 482 F. Supp. 2d 390